273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023

Werner Stenzel, Andrew L Mammen, Laure Gallay, Marie-Therese Holzer, Felix Kleefeld, Olivier Benveniste, Yves Allenbach, ENMC Antisynthetase Syndrome Study Group, Louise Pyndt Diederichsen (Member of study group)

Abstract

Among the idiopathic inflammatory myopathies, patients harbouring an Antisynthetase syndrome exhibit a unique clinical picture, with characteristic signs such as myositis, interstitial lung disease, arthritis, rash, and/or fever. Characteristic morphological features on skeletal muscle biopsies differentiate Antisynthetase syndrome from other forms of myositis. Autoantibodies typically recognizing one of the members of the aminoacyl-tRNA synthetase family of proteins can be detected in the serum of such patients, with anti-Jo1 being most frequent. Until now, an international consensus definition of the Antisynthetase syndrome is lacking, hence this workshop has undertaken the task to inform about the clinical, morphological and autoantibody profiles of Antisynthetase syndrome. The authors also expand their aims by giving management and therapeutic strategies, and finally provide precise classification criteria for Antisynthetase syndrome.

Original languageEnglish
Article number104453
JournalNeuromuscular disorders : NMD
Volume45
ISSN0960-8966
DOIs
Publication statusE-pub ahead of print - 4 Oct 2024

Fingerprint

Dive into the research topics of '273rd ENMC International workshop: Clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27-29 October 2023'. Together they form a unique fingerprint.

Cite this